Drug
Sodium chloride tablets
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(33%)
Phase Distribution
Ph not_applicable
1
33%
Ph phase_4
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution3 total trials
Phase 4Post-market surveillance
2(66.7%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Terminated(1)
Detailed Status
Not yet recruiting2
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
0.0%
Most Advanced
Phase 4
Trials by Phase
Phase 42 (66.7%)
N/A1 (33.3%)
Trials by Status
terminated133%
not_yet_recruiting267%
Recent Activity
0 active trials
Showing 3 of 3
not_yet_recruitingphase_4
The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease
NCT07487831
not_yet_recruitingphase_4
The Impact of Dietary Salt on the Severity of Eczema
NCT07447063
terminatednot_applicable
Oral Versus Intravenous Hydration to Prevent Contrast Induced Nephropathy
NCT01654328
Clinical Trials (3)
Showing 3 of 3 trials
NCT07487831Phase 4
The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease
NCT07447063Phase 4
The Impact of Dietary Salt on the Severity of Eczema
NCT01654328Not Applicable
Oral Versus Intravenous Hydration to Prevent Contrast Induced Nephropathy
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3